traffic analytics Rx&D - Canada's Research Based Pharmaceutical Companies
  Rx&DAbout Rx&DPharmaceutical Community
PublicationsMedia CentreStakeholders & PartnershipsMember's Login
 
 
 
  Forgot Password?
  Account Application
Rx&D HomeFrançaisContact Us
Useful LinksSite Map
  Pharmaceutical Community

Code of Conduct - Question & Answers

13. Advisory Boards - April 2005
 

Question 1:

Section 13.3 of the Code states that "Advisory Boards must consist of no more than 20 individuals." Does this 20 include solely HCPs or would it still be acceptable to have 20 HCP and 8 additional non-HCP individuals (i.e. Sales Representatives)?

Response:
The 20 refers to HCPs, however keep in mind that sales representatives should not be in attendance at Advisory boards.


Revised: June 06, 2005
 
 
Back to top

Home | About Rx&D | Pharmaceutical Community | Publications | Media Centre | Stakeholders & Partnerships
Useful Links | Français | Contact Us | Site Map

55 Metcalfe Street, Suite 1220, Ottawa, Ontario K1P 6L5
Tel.: (613) 236-0455 Reception Fax: (613) 236-6756
Strategic Affairs & Communications Fax: (613) 236-6861
Federal Affairs Fax: (613) 236-7919
© 2007 Rx&D Terms and Conditions of Use
All Rights Reserved